{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T16:57:04Z","timestamp":1774025824307,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005687","name":"Goethe-Universit\u00e4t Frankfurt am Main","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005687","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.jaut.2023.103161","type":"journal-article","created":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T10:16:50Z","timestamp":1703240210000},"page":"103161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Gene-expression profiling of laser-dissected islets and studies in deficient mice reveal chemokines as differential driving force of type 1 diabetes"],"prefix":"10.1016","volume":"143","author":[{"given":"Christine","family":"Bender","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilla","family":"Tondello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Horn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Holdener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanley","family":"Lasch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Bayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josef M.","family":"Pfeilschifter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Tacke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin-Leo","family":"Hansmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"D\u00f6ring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edith","family":"Hintermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4165-7976","authenticated-orcid":false,"given":"Urs","family":"Christen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2023.103161_bib1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","article-title":"Type 1 diabetes","volume":"383","author":"Atkinson","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2023.103161_bib2","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1080\/14656566.2018.1483339","article-title":"Non-insulin pharmacological therapies for treating type 1 diabetes","volume":"19","author":"Frandsen","year":"2018","journal-title":"Expet Opin. Pharmacother."},{"key":"10.1016\/j.jaut.2023.103161_bib3","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/cei.12085","article-title":"Progress in immune-based therapies for type 1 diabetes","volume":"172","author":"von Herrath","year":"2013","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2023.103161_bib4","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.3389\/fimmu.2017.01279","article-title":"Clinical tolerogenic dendritic cells: exploring therapeutic impact on human autoimmune disease","volume":"8","author":"Phillips","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2023.103161_bib5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/imm.12867","article-title":"Harnessing the power of regulatory T-cells to control autoimmune diabetes: overview and perspective","volume":"153","author":"Yu","year":"2018","journal-title":"Immunology"},{"key":"10.1016\/j.jaut.2023.103161_bib6","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.2337\/db13-0345","article-title":"Teplizumab (anti-CD3 mAb) treatment preserves C-peptide responses in patients with new-onset type 1 diabetes in a randomized controlled trial: metabolic and immunologic features at baseline identify a subgroup of responders","volume":"62","author":"Herold","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.jaut.2023.103161_bib7","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00125-018-4786-9","article-title":"Treatment of type 1 diabetes with teplizumab: clinical and immunological follow-up after 7 years from diagnosis","volume":"62","author":"Perdigoto","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.jaut.2023.103161_bib8","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0140-6736(11)60931-8","article-title":"Teplizumab for treatment of type 1 diabetes (Protege study): 1-year results from a randomised, placebo-controlled trial","volume":"378","author":"Sherry","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2023.103161_bib9","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.2337\/dc13-0327","article-title":"Low-dose otelixizumab anti-CD3 monoclonal antibody DEFEND-1 study: results of the randomized phase III study in recent-onset human type 1 diabetes","volume":"37","author":"Aronson","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jaut.2023.103161_bib10","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0092-8674(91)90165-U","article-title":"Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response","volume":"65","author":"Oldstone","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2023.103161_bib11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/1074-7613(94)90101-5","article-title":"How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model","volume":"1","author":"von Herrath","year":"1994","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2023.103161_bib12","doi-asserted-by":"crossref","first-page":"6838","DOI":"10.4049\/jimmunol.171.12.6838","article-title":"Among CXCR3 chemokines, IFN-gamma-inducible protein of 10 kDa (CXC chemokine ligand (CXCL) 10) but not monokine induced by IFN-gamma (CXCL9) imprints a pattern for the subsequent development of autoimmune disease","volume":"171","author":"Christen","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2023.103161_bib13","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.2337\/db15-0479","article-title":"Anti-CD3\/anti-CXCL10 antibody combination therapy induces a persistent remission of type 1 diabetes in two mouse models","volume":"64","author":"Lasch","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.jaut.2023.103161_bib14","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1128\/MCB.20.11.4106-4114.2000","article-title":"Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion","volume":"20","author":"Jung","year":"2000","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.jaut.2023.103161_bib15","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.4049\/jimmunol.165.6.3284","article-title":"The primate lentiviral receptor Bonzo\/STRL33 is coordinately regulated with CCR5 and its expression pattern is conserved between human and mouse","volume":"165","author":"Unutmaz","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2023.103161_bib16","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1006\/clim.2001.5178","article-title":"Impaired T cell function in RANTES-deficient mice","volume":"102","author":"Makino","year":"2002","journal-title":"Clin. Immunol."},{"issue":"Suppl 1","key":"10.1016\/j.jaut.2023.103161_bib17","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1093\/bioinformatics\/18.suppl_1.S96","article-title":"Variance stabilization applied to microarray data calibration and to the quantification of differential expression","volume":"18","author":"Huber","year":"2002","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jaut.2023.103161_bib18","series-title":"Exploratory Data Analysis","author":"Tukey","year":"1977"},{"key":"10.1016\/j.jaut.2023.103161_bib19","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2337\/db16-0547","article-title":"Islet-expressed CXCL10 promotes autoimmune destruction of islet isografts in mice with type 1 diabetes","volume":"66","author":"Bender","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.jaut.2023.103161_bib20","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/nm1202-792","article-title":"Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis","volume":"8","author":"Frigerio","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2023.103161_bib21","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1365-2249.2009.04087.x","article-title":"Islet inflammation and CXCL10 in recent-onset type 1 diabetes","volume":"159","author":"Roep","year":"2010","journal-title":"Clin. Exp. Immunol."},{"issue":"2012","key":"10.1016\/j.jaut.2023.103161_bib22","doi-asserted-by":"crossref","first-page":"436","DOI":"10.2337\/db11-0853","article-title":"Expression and regulation of chemokines in murine and human type 1 diabetes","volume":"61","author":"Sarkar","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.jaut.2023.103161_bib23","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.4049\/jimmunol.2000253","article-title":"Chemokine signatures of pathogen-specific T cells I: effector T cells","volume":"205","author":"Eberlein","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2023.103161_bib24","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.4049\/jimmunol.2000254","article-title":"Chemokine signatures of pathogen-specific T cells II: memory T cells in acute and chronic infection","volume":"205","author":"Davenport","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2023.103161_bib25","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1517\/14728222.2013.837886","article-title":"Targeting CCL5 in inflammation","volume":"17","author":"Marques","year":"2013","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.jaut.2023.103161_bib26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.gendis.2021.08.004","article-title":"CCL5\/CCR5 axis in human diseases and related treatments","volume":"9","author":"Zeng","year":"2022","journal-title":"Genes Dis"},{"key":"10.1016\/j.jaut.2023.103161_bib27","doi-asserted-by":"crossref","first-page":"993","DOI":"10.7754\/Clin.Lab.2012.120810","article-title":"Expression of CC chemokines CCL2, CCL5, and CCL11 is associated with duration of disease and complications in type-1 diabetes: a study on Iranian diabetic patients","volume":"59","author":"Jamali","year":"2013","journal-title":"Clin. Lab."},{"key":"10.1016\/j.jaut.2023.103161_bib28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.clim.2008.03.458","article-title":"Relation of circulating concentrations of chemokine receptor CCR5 ligands to C-peptide, proinsulin and HbA1c and disease progression in type 1 diabetes","volume":"128","author":"Pfleger","year":"2008","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jaut.2023.103161_bib29","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/eji.200324285","article-title":"Leukocyte attraction through the CCR5 receptor controls progress from insulitis to diabetes in non-obese diabetic mice","volume":"34","author":"Carvalho-Pinto","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2023.103161_bib30","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.immuni.2012.05.008","article-title":"The chemokine superfamily revisited","volume":"36","author":"Zlotnik","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2023.103161_bib31","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1172\/JCI11902","article-title":"Bonzo\/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential","volume":"107","author":"Kim","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jaut.2023.103161_bib32","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1189\/jlb.1204733","article-title":"Distribution and kinetics of SR-PSOX\/CXCL16 and CXCR6 expression on human dendritic cell subsets and CD4+ T cells","volume":"77","author":"Tabata","year":"2005","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jaut.2023.103161_bib33","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/ni.1953","article-title":"Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses","volume":"11","author":"Paust","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2023.103161_bib34","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.4049\/jimmunol.1101118","article-title":"Adjuvant immunotherapy of experimental autoimmune encephalomyelitis: immature myeloid cells expressing CXCL10 and CXCL16 attract CXCR3+CXCR6+ and myelin-specific T cells to the draining lymph nodes rather than the central nervous system","volume":"188","author":"O'Connor","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2023.103161_bib35","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/jid.2011.371","article-title":"CXCL16 and CXCR6 are upregulated in psoriasis and mediate cutaneous recruitment of human CD8+ T cells","volume":"132","author":"Gunther","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jaut.2023.103161_bib36","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.4049\/jimmunol.1202909","article-title":"Chemokine receptor CXCR6-dependent hepatic NK T Cell accumulation promotes inflammation and liver fibrosis","volume":"190","author":"Wehr","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2023.103161_bib37","article-title":"Evaluation of proteoforms of the transmembrane chemokines CXCL16 and CX3CL1, their receptors, and their processing metalloproteinases ADAM10 and ADAM17 in proliferative diabetic retinopathy","volume":"11","author":"Abu El-Asrar","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2023.103161_bib38","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1160\/TH07-01-0035","article-title":"Transmembrane chemokines: versatile 'special agents' in vascular inflammation","volume":"97","author":"Ludwig","year":"2007","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.jaut.2023.103161_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14030594","article-title":"Resveratrol inhibited ADAM10 mediated CXCL16-cleavage and T-cells recruitment to pancreatic beta-cells in type 1 diabetes mellitus in mice","volume":"14","author":"Abdel-Bakky","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jaut.2023.103161_bib40","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1124\/mi.10.5.3","article-title":"Fractalkine\/CX3CL1: a potential new target for inflammatory diseases","volume":"10","author":"Jones","year":"2010","journal-title":"Mol. Interv."},{"key":"10.1016\/j.jaut.2023.103161_bib41","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1161\/ATVBAHA.111.237412","article-title":"A survivor's guide: chemokines as antiapoptotic mediators","volume":"32","author":"White","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jaut.2023.103161_bib42","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.immuni.2016.10.018","article-title":"The chemokine receptor CX3CR1 defines three antigen-experienced CD8 T cell subsets with distinct roles in immune surveillance and homeostasis","volume":"45","author":"Gerlach","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2023.103161_bib43","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.4049\/jimmunol.1103725","article-title":"Functional specialization of islet dendritic cell subsets","volume":"188","author":"Yin","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2023.103161_bib44","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/cei.13239","article-title":"Pathogen infection and autoimmune disease","volume":"195","author":"Christen","year":"2019","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2023.103161_bib45","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2337\/db06-1384","article-title":"Murine antithymocyte globulin therapy alters disease progression in NOD mice by a time-dependent induction of immunoregulation","volume":"57","author":"Simon","year":"2008","journal-title":"Diabetes"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841123001701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841123001701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T03:31:31Z","timestamp":1717817491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841123001701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":45,"alternative-id":["S0896841123001701"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2023.103161","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene-expression profiling of laser-dissected islets and studies in deficient mice reveal chemokines as differential driving force of type 1 diabetes","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2023.103161","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103161"}}